Revance Therapeutics shares owned by HighTower Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by HighTower Advisors
from 13F filings
Historical chart of HighTower Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by HighTower Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.8M | 436k | 8.79 |
| 2023-09-30 | $3.3M | 290k | 11.47 |
| 2023-06-30 | $4.9M | 195k | 25.31 |
| 2023-03-31 | $9.8M | 305k | 32.20 |
| 2022-12-31 | $9.1M | 491k | 18.46 |
| 2022-09-30 | $23M | 855k | 27.00 |
| 2022-06-30 | $17M | 1.2M | 13.82 |
| 2022-03-31 | $24M | 1.2M | 19.50 |
| 2021-12-31 | $16M | 968k | 16.32 |
| 2021-09-30 | $24M | 860k | 27.86 |
| 2021-06-30 | $17M | 583k | 29.64 |
| 2021-03-31 | $19M | 687k | 27.95 |
| 2020-12-31 | $2.1M | 73k | 28.34 |
| 2020-09-30 | $2.4M | 97k | 25.13 |
| 2020-06-30 | $1.2M | 49k | 24.41 |
| 2020-03-31 | $648k | 44k | 14.83 |
| 2019-12-31 | $665k | 41k | 16.22 |
| 2019-09-30 | $367k | 28k | 13.01 |
| 2019-06-30 | $352k | 27k | 12.94 |
| 2019-03-31 | $410k | 26k | 15.77 |
| 2018-12-31 | $403k | 20k | 20.15 |
| 2018-09-30 | $547k | 22k | 24.86 |
| 2018-06-30 | $604k | 22k | 27.45 |
| 2018-03-31 | $678k | 22k | 30.82 |
| 2017-12-31 | $787k | 22k | 35.77 |